For example, in gastric carcinoma, a decrease in MUC5AC expression correlates with poor prognosis, whereas in pancreatic, colon, and lung cancers, an increase in MUC5AC correlates with poor prognosis [54,55,56,57,58]. Here, MUC5AC is linked to lung carcinoma.